Published in Women's Health Weekly, August 25th, 2005
"Our previous studies in rodent models of nephropathy demonstrate that 2-hydroxyestradiol (2HE), an estradiol metabolite with little estrogenic activity, exerts renoprotective effects. In vivo, 2HE is readily converted to 2-methoxyestradiol (2ME), a major estradiol metabolite with no estrogenic activity," researchers in the United States report.
S.P. Tofovic and colleagues of the University of Pittsburgh wrote, "The goal of [our present] study was to determine whether 2ME has renal and cardiovascular protective effects in vivo."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly